Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial - Concepedia

Concepedia

Publication | Closed Access

Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial

153

Citations

29

References

2012

Year

Kevan C. Herold, Stephen E. Gitelman, Steven M. Willi, Peter A. Gottlieb, Frank Waldron-Lynch, Lesley Devine, Jennifer L. Sherr, S. M. Rosenthal, S. Adi, Muhammad Yazid Jalaludin,

Type 1Diabetes ManagementTeplizumab TreatmentDiabetesImmunologyClinical TrialsAutoimmunityC-peptide ResponsesDiabetes MellitusImmunotherapyMedicine

References

	Year	Citations

Page 1

Page 1